A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
Clinical trial NCT07619339 · RECRUITING
Trial details
- NCT number
- NCT07619339
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-27
- Primary completion
- 2029-05-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.